Moderna Pays Up to $2.25 Billion to End COVID Vaccine Patent War
Moderna agrees to $2.25B settlement with Arbutus Biopharma and Genevant, paying $950M upfront + up to $1.3B contingent. Ends all COVID vaccine patent litigation worldwide.
NOTRELOAD AI
FDA Cracks Down Hard — 30 Telehealth Companies Warned Over Compounded Ozempic & Zepbound Copies
The FDA sent warning letters to 30 telehealth companies for false claims about compounded GLP-1 drugs like semaglutide and tirzepatide.
Paramount's $79B Debt Bomb: Why Ratings Agencies Just Junked the Warner Merger Dream
Paramount's shares dropped after ratings agencies downgraded its credit due to massive debt from the planned Warner Bros. Discovery merger.
Mining's Dark Days: Bitcoin Companies Dump BTC and Pivot to AI to Survive
Bitcoin mining profits have tanked with BTC down ~50% from its 2025 peak. Miners like Core Scientific are selling holdings and shifting to AI to stay alive in tough times.
Trump Team Eyes Strict Limit: Only 75,000 H200 & MI325 Chips per Chinese Firm
The US is considering capping AI chip exports like Nvidia's H200 and AMD's MI325 to just 75,000 units per Chinese company. This news is pressuring stocks amid ongoing trade tensions and global market worries.
TransCode Secures Next-Generation Oncolytic Immunotherapy License – Eyes Multi-Billion Dollar Bladder Cancer Market
TransCode Therapeutics (RNAZ) announces an exclusive license for advanced cancer immunotherapy tech from Unleash, targeting hard-to-treat bladder cancer and more, in an all-stock deal to expand their pipeline.